157 related articles for article (PubMed ID: 32216452)
1. Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation.
Tegel BR; Huber S; Savic LJ; Lin M; Gebauer B; Pollak J; Chapiro J
Acta Radiol; 2020 Dec; 61(12):1708-1716. PubMed ID: 32216452
[TBL] [Abstract][Full Text] [Related]
2. The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.
Shakeri S; Afshari Mirak S; Mohammadian Bajgiran A; Pantuck A; Sisk A; Ahuja P; Lu DS; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2308-2315. PubMed ID: 30847565
[TBL] [Abstract][Full Text] [Related]
3. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH
Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684
[TBL] [Abstract][Full Text] [Related]
4. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
5. Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation.
Curci NE; Triche BL; Abel EJ; Bhutani G; Maciolek KA; Dreyfuss LD; Allen GO; Caoili EM; Davenport MS; Wells SA
Eur Radiol; 2021 Aug; 31(8):5490-5497. PubMed ID: 33492471
[TBL] [Abstract][Full Text] [Related]
6. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
7. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.
Maxwell AWP; Baird GL; Iannuccilli JD; Mayo-Smith WW; Dupuy DE
Radiology; 2017 May; 283(2):590-597. PubMed ID: 27875105
[TBL] [Abstract][Full Text] [Related]
8. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
10. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
12. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
13. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
15. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
16. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
[TBL] [Abstract][Full Text] [Related]
18. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
19. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
20. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors.
Hao G; Hao Y; Cheng Z; Zhang X; Cao F; Yu X; Han Z; Liu F; Mu M; Dou J; Li X; Dupuy DE; Yu J; Liang P
Int J Hyperthermia; 2018; 35(1):62-70. PubMed ID: 29807450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
